Paliperidone Palmitate
| Code | Size | Price |
|---|
| TAR-T19950-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T19950-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Paliperidone is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. Paliperidone has an antagonist effect at α1 and α2 adrenergic receptors and at H1 histamine receptors. In addition, it binds with dopamine and serotonin receptors.
CAS:
199739-10-1
Formula:
C39H57FN4O4
Molecular Weight:
664.907
Purity:
0.98
SMILES:
CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(CC1)c1noc3cc(F)ccc13)c2=O
References
1. Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population. J Comp Eff Res. 2018 May 3. doi: 10.2217/cer-2018-0003. [Epub ahead of print] PubMed PMID: 29722547.
2. Deslandes PN, Ward EH, Norris K, Sewell RD. Effectiveness of paliperidone long-acting injection in clinical practice. Ther Adv Psychopharmacol. 2018 May;8(5):139-145. doi: 10.1177/2045125317753332. Epub 2018 Jan 17. PubMed PMID: 29713451; PubMed Central PMCID: PMC5896863.
3. Russu A, Kern Sliwa J, Ravenstijn P, Singh A, Mathews M, Kim E, Gopal S. Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations. Int J Clin Pract. 2018 Apr 30:e13089. doi: 10.1111/ijcp.13089. [Epub ahead of print] PubMed PMID: 29707876.
4. Jukic V, Jakovljevic M, Filipcic I, Herceg M, Silic A, Tomljanovic T, Zilbershtein R, Jensen RCD, Hemels MEH, Einarson TR. Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia. Value Health Reg Issues. 2013 Sep - Oct;2(2):181-188. doi: 10.1016/j.vhri.2013.06.008. Epub 2013 Sep 13. PubMed PMID: 29702863.